Ovarian cancer vaccine on trial
Links shared publicly online about this topic.
- 792total visits
Ovarian cancer vaccine on trial
View full resource at theage.com.au
Tags: Vaccination, Cancer, Ovarian Cancer, Women's Health, Vaccine
Most Recently Shared on October 18, 2010 at 2:31 pm By:
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial : The Lancet Oncology
thelancet.com — “Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. By - Ravi A Madan MD, Mahsa Mohebtash MD, ...” View full resource at thelancet.com
Most Recently Shared on May 1, 2012 at 5:37 pm By:
[Articles] Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resist... http://t.co/L9G879WO
Vaccine extends life of brain cancer patients - Yahoo! News India
in.news.yahoo.com — “'Vaccine extends life of brain cancer patients' on Yahoo! News India. Washington, April 19 (IANS) A new brain cancer vaccine, which uses material from patients' own tumours, holds promise of extending their lives by several months, show results of a multicentre phase-two clinical trial of the vaccine.” View full resource at in.news.yahoo.com
Most Recently Shared on April 19, 2012 at 1:05 pm By:
Vaccine extends life of brain cancer patients: Washington, April 19 (IANS) A new brain cancer vaccine, which use... http://t.co/Ui9dfsdf
New Brain Cancer Vaccine Displays Success In Second Clinical Trial - Health News - redOrbit
redorbit.com — “On Tuesday, April 17, researchers from the University of California, San Francisco (UCSF) presented results at the American Association of Neurological Surgeons (AANS) meeting in Miami, Florida that a new brain cancer vaccine tailored to individual subjects had been successful in its second clinical trial.” View full resource at redorbit.com
Most Recently Shared on April 18, 2012 at 7:03 pm By:
New Brain Cancer Vaccine Displays Success In Second Clinical Trial: Connie K. Ho for http://t.co/nBP7sQqf On Tues... http://t.co/iwLUkdAv
Belagenpumatucel-L improves survival for patients with stage 3B/4 NSCLC
news-medical.net — “Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Belagenpumatucel-L improves survival for patients with stage 3B/4 NSCLC: Long-term follow-up o... http://t.co/f8eeFaIJ
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data | BMJ
bmj.com — “Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data | BMJ” View full resource at bmj.com
Most Recently Shared on March 27, 2012 at 10:30 pm By:
Cervical disease sufferers could benefit from HPV vaccine http://t.co/CHh3iPH2
Pox vaccines extend survival for patients with melanoma, ovarian cancer
medicalxpress.com — “An immunotherapy regimen incorporating poxviruses and targeting a particular tumor antigen, NY-ESO-1, has shown promise in treating two types of cancers. Kunle Odunsi, MD, PhD, Chair of the Department of Gynecologic Oncology and Director of the Center for Immunotherapy at Roswell Park Cancer Institute ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 10:20 pm By:
PhysOrg Health News Health News
Pox vaccines extend survival for patients with melanoma, ovarian cancer http://t.co/nohDd8u7
Pox Vaccines Extend Survival for Patients with Melanoma, Ovarian Cancer in U.S., German Studies
newswise.com — “Researchers from Roswell Park Cancer Institute, Krankenhaus Nordwest and two other institutions have published results of parallel phase II studies testing a promising immunotherapy regimen in patients with melanoma and ovarian cancer” View full resource at newswise.com
Most Recently Shared on March 26, 2012 at 8:27 pm By:
Pox Vaccines Extend Survival for Patients with Melanoma, Ovarian Cancer in U.S., German Studies: Researchers fro... http://t.co/gdLC2pTA
Ovarian cancer vaccine: Can it prevent recurrence? - MayoClinic.com
mayoclinic.com — “Research continues to evaluate the role of an ovarian cancer vaccine to prevent recurrence.” View full resource at mayoclinic.com
Most Recently Shared on March 24, 2012 at 2:20 am By:
Julie Bohlen Active Health Library and Health Executive
Ovarian cancer vaccine: Can it prevent recurrence?: Research continues to evaluate the role of an ovarian cancer... http://t.co/fbwU0zDZ
Ovarian cancer drug trials to start soon | Adelaide Now
adelaidenow.com.au — “CLINICAL trials for a new Adelaide-developed ovarian cancer drug are expected to start by the middle of the year.” View full resource at adelaidenow.com.au
Most Recently Shared on March 23, 2012 at 2:16 pm By:
Ovarian cancer drug trials to start soon: CLINICAL trials for a new Adelaide-developed ovarian cancer drug are e... http://t.co/KaJEsm4Q
New therapy may help ovarian cancer patients | News.com.au
news.com.au — “AN Australian drug developer will in coming months begin recruiting 120 women with ovarian cancer for a clinical trial of a new therapy.” View full resource at news.com.au
Most Recently Shared on March 23, 2012 at 2:16 pm By:
New hope for ovarian cancer patients: AN Australian drug developer will soon begin recruiting 120 women with ova... http://t.co/aFgxgQva
ImmunoCellular licenses new ovarian cancer target - FierceVaccines
fiercevaccines.com — “Ovarian cancer is a quiet killer, with symptoms that are easily confused with other, less serious illnesses, so it often isn't spotted until it's quite advanced. ImmunoCellular Therapeutics Read more...” View full resource at fiercevaccines.com
Most Recently Shared on March 22, 2012 at 3:06 pm By:
ImmunoCellular licenses new ovarian #cancer target from University of Pittsburgh http://t.co/5QYffgRs
Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial - Sutcliffe - 2012 - BJU International - Wiley Online Library
onlinelibrary.wiley.com — “Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial - Sutcliffe - 2012 - BJU International - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 20, 2012 at 12:40 pm By:
Non‐steroidal anti‐inflammatory drug use and the risk of benign prostatic hyperplasia‐related outcomes and noctu... http://t.co/LwqwfB7R
Oncology News - Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer |3982749
mdlinx.com — “Oncology Medical Article: Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on March 20, 2012 at 7:52 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian c... http://t.co/y4Q5ymYk #oncology
Treatment of Elderly Ovarian Cancer Patients in th... [Onkologie. 2012] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 17, 2012 at 6:29 am By:
Treatment of Elderly Ovarian Cancer Patients in the Context of Controlled Clinical Trials: A Joint Analysis of t... http://t.co/cUzHRzzJ
Hep C vaccine heads into further clinical trials - FierceVaccines
fiercevaccines.com — “Hepatitis C virus infection is spread through the blood, and it can lead to liver cirrhosis and is the leading cause of liver cancer. Okairos, a spinout from Merck ($MRK), is starting a Phase I/II Read more...” View full resource at fiercevaccines.com
Most Recently Shared on March 15, 2012 at 1:25 pm By:
Vaccinate against HepC, avoid interferon? http://t.co/gwk9qFwD
Advertisement
